|
Contact: Michael McManus
President & COO
(978) 934-8821, Ext. 129
E-mail: mmcmanus@anvilinformatics.com
Contact: Howard Berke
CEO
(978) 934-8821, Ext. 401
E-mail: hberke@anvilinformatics.com
June 13, 2000
Industry Veteran Dr. Frank Hurley Elected AnVil Informatics's Chairman of the Board
Lowell, MA AnVil Informatics, Inc. has named Frank
Hurley, Ph.D. as its Chairman of the Board of
Directors. AnVil has also secured additional working
capital resources through an "angel" financing
in which Potomac Healthcare Ventures participates.
"As the co-founder
of BRI and former CSO of Quintiles, Dr.
Hurley has salient experience and in-depth
knowledge of how to build a successful professional
service company from ground up." said Howard
Berke, AnVil's Chief Executive Officer.
"Dr. Hurley is highly regarded in the pharmaceutical,
medical devices and diagnostic fields. These
are the market segments which are the initial
client focus of AnVil. Dr. Hurley will provide
invaluable guidance on the company's future
direction and operation."
"AnVil Informatics
has already established itself with a viable
business model, experienced management team,
knowledgeable scientific advisory committee
and having secured initial consulting client
companies." said Dr. Hurley. "I look forward
to continuing to work with the team in this
exciting and emerging bioinformatics field
to further enhance Anvil's market leadership."
Dr. Frank Hurley was a co-founder
of Biometric Research Institute (later known
as BRI International) where he held a position
of Chairman and Chief Scientific Officer
until BRI's merger with Quintiles Transnational
Corporation (NasdaqNM:QTRN). He served as
Quintiles Chief Scientific Officer and currently
is holding a position of Senior Scientist.
He is also an Adjunct Professor of Biostatistics
and Epidemiology at Georgetown University.
Dr. Hurley received his BS
in Mathematics from Georgetown University
and his Ph.D. in Biostatistics from John
Hopkins University.
Founded in 1999, AnVil Informatics,
Inc. provides data mining and visualization
services to leading pharmaceutical and biotechnology
companies. AnVil's combination of unique,
internally developed software and commercial
tools allows for the exploration of complex,
large and high dimensional datasets. In
addition, AnVil's technical experts harness
different properties of human perception
such as color, texture and shape in the
process of visualizing various attributes
of the complex data and their full distributions.
The resulting visualizations make conclusions
more evident earlier in the decision making
process and can greatly enhance every step
of the client's decision making process--helping
them to make informed decisions faster and
more accurately.
To learn more about AnVil's
capabilities and offerings, visit the web
site at www.anvilinformatics.com.
|